NTEC News

Equity Selloff Hits Recent IPOs Recent IPOs have not been exempt from the steep selloff in the major indices. As of midday Friday, the Renaissance IPO Index was down 5.6% for the week, underperforming the S&P 500's -4.3% return. One of the most prominent IPOs of recent memory,...read more

Biotech companies lead a weak week in IPOs. So far this year, 127 companies have come public, and the average first-day pop has been about 16%. In the past two weeks, 8 of 12 IPOs ended their first day down or flat. The downward trend accelerated this week with an average first-day return...read more

Intec Pharma, which is developing an improved delivery method of carbidopa/levodopa for Parkinson's disease, raised $30 million by offering 5 million shares at $6. In early trading on the Nasdaq (symbol NTEC), the stock was trading slightly below $6, down 3-5%. Intec Pharma previously traded on the Tel Aviv Stock Exchange and initially filed confidentially for a US listing on...read more

August 2015 kicks off with ten IPOs on the calendar for this week - more IPOs than all of August 2014 - after a slower than average July. Based on the number of ...read more